Drugmakers’ worst performance will likely rekindling of kickbacks

The country’s pharmaceutical companies including top-tier ones have struggled to find their feet during the first half, even after a government-mandated price cut came into effect last year.

They are still feeling the brunt of government-imposed price cuts, subduing marketing activities triggered by the government’s incessant crackdown on illegal kickbacks and low consumption.

“The atmosp...